Any stock, in context
VIVIMEDLAB · Healthcare
Vivimed Labs Limited
Observation · 15 Oct 2026
How these are readVivimed Labs closed at ₹6.710 on 15 Oct 2026, 5.7% below its 200-day average and 12.3% above its 50-day average: below the long line, above the short one. It sits 74.8% below its highest close of the past year, in the bottom fifth of its one-year range. Over three months it rose 28.3%, against a median of −2.7% for its sector (146 stocks) and −5.1% for every stock observed.
- Trade-for-trade (BE series)
- Thinly traded: under ₹1 crore a day
- vs 200-day
- −5.7%
- the long line
- vs 50-day
- +12.3%
- the short line
- From 52w high
- −74.8%
- ₹4.750₹29.40
- 3 months
- +28.3%
- sector median −2.7% · 14 of 146
Listed outside the Nifty indices · Healthcare (sector mapped from its industry) · BE series (trade-for-trade) · median traded value ₹0.03 crore a day. A description of where the price sits, not a view on the stock.
- 1D
- −1.90%
- 1W
- –
- 1M
- +13.54%
- 3M
- +28.30%
- YTD
- –
- 1Y
- +35.56%
Quotes come from Yahoo Finance through this site's server and are cached for fifteen minutes; when the provider fails, the stored close is shown and labelled. The observation is computed from the latest snapshot. For research and education only; not investment advice.